LABORIE Medical Technologies Announces Completion of Clinical Innovations Acquisition

BURLINGTON, Mass. and SALT LAKE CITY, Feb. 12, 2020 /PRNewswire/ --Laborie Medical Technologies, a leading diagnostic and therapeutic medical technology company, today announced it has completed its acquisition of Clinical Innovations for an enterprise value of $525 million.

Based in Salt Lake City, Clinical Innovations is a leading global provider of clinician-preferred medical devices for the labor & delivery (L&D) and neonatal intensive care unit (NICU) specialties.

“We are pleased to welcome the incredibly talented Clinical Innovations team to the LABORIE family,” commented Michael Frazzette, President & CEO of LABORIE Medical Technologies. “We look forward to investing in, and building upon Clinical Innovations’ unique product portfolio and specialty channels to continue to benefit mothers, babies and healthcare professionals around the world.”

In order to drive the focus, resources, investments and customer-intense culture needed to continue to be successful in the L&D and NICU specialties, the Clinical Innovations business will form a stand-alone Global Business Unit (GBU) called Maternal and Child Health.

“This focused GBU approach will enable us to build on Clinical Innovations’ established strong and trusted relationships with physicians and nurses; and serve the distinct customer call point of obstetricians, gynecologists, neonatologists, and NICU and L&D nurses,” Frazzette added.

“We look forward to leveraging Patricia Industries’ healthcare expertise and global presence to support the combined LABORIE and Clinical Innovations organization as we embark on our next phase of growth together,” said Yuriy Prilutskiy, Managing Director at Patricia Industries, a part of Investor AB, and owner of LABORIE Medical Technologies. “Consistent with our purpose of creating value for people and society by building strong and sustainable businesses, we will continue to invest in and develop the company to improve clinical outcomes for patients around the world for many years to come.”

Piper Jaffray acted as financial advisor and Cleary Gottlieb Steen & Hamilton LLP as legal advisor to LABORIE.

About LABORIE Medical Technologies
LABORIE is a leading global developer, manufacturer and marketer of innovative medical technology and consumables used in gastrointestinal procedures and for the diagnosis and treatment of pelvic health in the Urology, Gynecology, and Colorectal fields. LABORIE is a portfolio company of Patricia Industries. For more information, visit laborie.com.

About Patricia Industries
Patricia Industries, a part of Investor AB, makes control investments in best-in-class companies with strong market positions, brands and corporate cultures within industries positioned for secular growth. Our ambition is to be the sole owner of our companies, together with strong management teams and boards. We invest with an indefinite holding period and focus on building durable value and capturing organic and non-organic growth opportunities.

About Investor AB
Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies. We have a long-term investment perspective. Through board participation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class. Our holdings include among others ABB, Atlas Copco, Ericsson, Mölnlycke and SEB. For more information, visit www.investorab.com.

View original content:http://www.prnewswire.com/news-releases/laborie-medical-technologies-announces-completion-of-clinical-innovations-acquisition-301003244.html

SOURCE LABORIE Medical Technologies